Clinical Trial Update: Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial evaluating cyclosporine, interferon gamma, and interleukin-2 after high-dose myeloablative chemotherapy with autologous stem cell transpla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Interferon-gamma (interferon gamma)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Children's Oncology Group | Conditions: Lymphoma | Phase 2, Phase 3 | Status: COMPLETED